Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
Iracema Leroi(Trinity College Dublin), Piers Dawes(The University of Queensland), Mark Hann(Manchester Academic Health Science Centre), Emma Hooper(University of Manchester), Jemma Regan(Manchester Academic Health Science Centre), Ines Himmelsbach(Catholic University of Applied Sciences Freiburg), David Reeves(Manchester Academic Health Science Centre), Zoë Simkin(University of Manchester), Chryssoula Thodi(European University Cyprus), Fan Yang(Ningbo University), Éric Frison(Université de Bordeaux), Fidéline Collin(Université de Bordeaux)
Cited by 33
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223
Impact of the COVID-19 Pandemic on Loneliness and Social Isolation: A Multi-Country Study
|International Journal of Environmental Research and Public Health|2021|208